Molecular Weight(MW): 371.45
SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.
3 Customer Reviews
Interaction between Src and FAK during ILTV infection in LMH cells. The protein levels of FAK, phosphorylated FAK (p-FAK), Src, and phosphorylated Src (p-SRC) were assayed in LMH cells with or without ILTV infection upon pretreatment with SU6656. β-Tubulin or β-actin was used as a loading control. The intensity ratio between the corresponding bands (upper band/lower band) was determined using ImageJ and normalized to the ratio of DMSO.
J Virol, 2015, 90(1):9-21. SU6656 purchased from Selleck.
(B) IP3 levels measured by ELISA in CD36OE and vector control of HepG2.2.15 and HepAD38 cells (n = 3) (*P < 0.05). (C) Src kinase inhibitor (SU6656) decreases cytosolic Ca2+ in CD36OE of HepG2.2.15 and HepAD38 cells. SU6656 or vehicle controls (DMSO) were added to the CD36OE of HepG2.2.15 and HepAD38 cells for 24 h, Cytosolic Ca2+ was measured after treatment using flow cytometry (n = 3) (*** p < 0.001). (D) Src kinase inhibitor (SU6656) overrides the higher HBV replication induced by CD36 overexpression. SU6656 or vehicle controls (DMSO) were added to the CD36 overexpression of HepG2.2.15 and HepAD38 cells for 96 h. HBV DNA were extracted and detected by real-time PCR (n = 4). (**P < 0.01 and*** p < 0.001).
Exp Cell Res, 2017, 358(2):360-368. SU6656 purchased from Selleck.
Purity & Quality Control
Choose Selective Src Inhibitors
|Description||SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.|
In NIH 3T3 cells, SU 6656 inhibits the PDGF-stimulated S-phase induction with IC50 of 0.3-0.4 μM. SU 6656 also inhibits PDGF- and serum-mediated NIH 3T3 cell proliferation, as well as epidermal growth factor and colony-stimulating factor 1-stimulated DNA synthesis in normal and colony-stimulating factor 1 receptor transfected NIH 3T3 cells. SU6656 inhibits PDGF-stimulated c-Myc induction and ERK2 activation. Pretreating Jurkat T-cells with SU 6656 leads to increased VSV-G luciferase activity. SU 6656 impairs TGF-β-mediated upregulation of CTGF mRNA and protein in proximal epithelial HKC-8 cells, and also reduces CTGF expression in cells exposed to autocrine growth factors. SU 6656 interferes with Aurora kinase activity resulting in inhibition of cell division and formation multilobular nuclei.
|In vivo||SU 6656 markedly and dose-dependently attenuates mecamylamine-induced experimental nicotine withdrawal syndrome in mice measured in terms of WSS and anxiety score. Once-daily administration of SU 6656 (1.5, 3, and 6 mg/kg, i.p.) markedly and dose-dependently attenuates the naloxone-induced morphine withdrawal syndrome.|
Biochemical kinase assays for IC50 determination and kinetic studies:IC50 measurements are made using poly-Glu–Tyr (4:1), or, in the case of Lck, poly-Lys–Tyr (4:1) as a peptide substrate. The divalent cation is 20 mM MgCl2 (in the case of Src, Fyn, Yes, Lyn, Csk, Frk, or Abl) or 10 mM MnCl2 (in the case of FGFR1, IGF1R, Lck, or Met). The ﬁnal ATP concentrations are as follows: Src, 10 μM; Fyn, 6 μM; Yes, 100 μM; Lyn, 2 μM; Csk, 10 μM; Frk, 10 μM; Abl, 4 μM; FGFR1, 10 μM; IGF1R, 2 μM; Lck, 2 μM; Met, 5 μM; PDGFR, 6 μM. IC50 measurements of PDGFRb autophosphorylation are determined on immunoprecipitated PDGFRb. Km values are calculated using the Eadie-Hofstee method.
-  Blake RA, et al. Mol Cell Biol. 2000, 20(23), 9018-9027.
-  McCarthy SD, et al. J Acquir Immune Defic Syndr.?014, 66(2), 118-126.
-  Cichal I, et al. Int J Biochem燙ell燘iol.?014, 46, 39-48.
|In vitro||DMSO||74 mg/mL warmed (199.21 mM)|
|In vivo||Add solvents to the product individually and in order:
10% DMSO+dd H2O
For best results, use promptly after mixing.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).
Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )
* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).
Molecular Weight Calculator
Enter the chemical formula of a compound to calculate its molar mass and elemental composition:
Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2
Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.